MAIA Biotechnology MAIA
NYSE MAIA
$1.03 -0.03 (-2.83%)
At close: Nov 11, 2026 · 4:00 PM EST

MAIA Biotechnology (MAIA) Change in Other Operating Liabilities (2022)

Updated

MAIA Biotechnology's Change in Other Operating Liabilities came in at $3,062 for Q1 2022.

Analysis

MAIA Biotechnology (MAIA) Change in Other Operating Liabilities (2022) Analysis & Trends

For FY2021, MAIA Biotechnology's Change in Other Operating Liabilities was -$7,037.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.69 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -34.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -113.00 Mn
10 MAIA Biotechnology 65.45 Mn -26.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 3,062.00
API Access

MAIA Biotechnology Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=MAIA&period=max&api_key=YOUR_API_KEY